- Ongoing, recruitingTherapeutic exploratory (Phase II)
A 4-Week, Phase II, Multicenter, Randomized, Double-Masked, Vehicle-Controlled, Parallel Group Study With 2 Weeks of Follow-Up to Evaluate Safety and Efficacy of Two Different Dosages of Isocyclosporin A Eye Drop Solution Versus Vehicle in Adult Patients with Atopic Keratoconjunctivitis (AKC).
This study is testing a new eye drop called Isocyclosporin A for adults with a severe allergic eye condition called Atopic Keratoconjunctivitis (AKC). It aims to see if the drops can reduce itchy eyes and are safe to use.
For: Atopic keratoconjunctivitis (AKC)Italy - Ongoing, recruitingTherapeutic exploratory (Phase II)
A 4-Week, Phase II, Multicenter, Randomized, Double-Masked, Vehicle-Controlled, Parallel Group Study With 4 Weeks of Follow-Up to Evaluate Safety and Efficacy of a new formulation of Recombinant Human Nerve Growth Factor (rhNGF) Eye Drop Solution at two different Concentrations in patients with Dry Eye Disease (REDUCO study)
This study is testing a new eye drop for dry eye disease. It uses a man-made version of a natural body substance to see if it improves dry eye symptoms and overall eye health over 8 weeks, with a follow-up period.
For: Dry EyeItaly